Navigation Links
Treatment Advances Improve the Odds for Heart Failure Patients
Date:2/16/2012

By Alan Mozes
HealthDay Reporter

THURSDAY, Feb. 16 (HealthDay News) -- Although a growing number of Americans now struggle with heart failure, experts say new treatments have dramatically improved both quality of life and life expectancy for these patients.

"The present environment for heart failure is substantially improved, and the future holds promises that will truly remove the term 'failure' from the description of this illness," said Dr. Gregg Fonarow, director of the Ahmanson-UCLA Cardiomyopathy Center in Los Angeles and co-director of the Preventive Cardiology Program at UCLA's David Geffen School of Medicine.

Dr. Clyde Yancy, past president of the American Heart Association and chief of cardiology at Northwestern Memorial Hospital in Chicago, seconded that notion, pointing to what he sees as "the edge of a new dawn" in which advances in treatment will enable clinicians to "take the heft, the drama and the 'failure' out of heart failure."

To raise public awareness, the American Heart Association has deemed this week National Heart Failure Awareness Week.

A little understood medical condition, the symptoms of heart failure include extreme fatigue, weakness and/or shortness of breath, as years of poor nutrition, inactivity, high blood pressure, high cholesterol, excessive weight and related health complications, such as diabetes, take a cumulative toll on an ever-weakening heart.

In turn, the heart muscle strains, and ultimately fails, to carry out its continuous duty of pumping blood (and the oxygen it carries) throughout the body. This makes everyday acts such as walking or climbing stairs a major effort for patients. Heart failure is now estimated to affect 6 million men and women in the United States.

"Anybody in the population over the age of 40 has a 20 percent chance of developing heart failure, regardless of your medical history," Yancy said. "Which means, in short, that all of us are at risk. And of course those with a history of heart disease have an even higher risk."

However, Yancy noted, "just a few years ago we had nothing we could say that was particularly encouraging. It wasn't a disease for which there was much hope or optimism. But that has totally turned around now."

Why?

Fonarow credits the shift to a decade of drug and medical device innovation. On the one hand, there is the advent of whole new classes of medications -- such as ACE inhibitors, beta blockers and aldosterone antagonists -- that help lower the risk for developing heart failure, while expanding treatment options when it does strike.

And, Yancy added, "We also know that cardiac rehabilitation -- namely an exercise regimen -- can also help. Years ago, we told patients to just take it easy. But, now we know that an active vigorous lifestyle is actually a better way to go."

At the same time, Fonarow pointed to the rise of small, affordable and effective implantable electrical devices that have helped physicians better control the sort of electrical disturbances of the heart that can harm normal function.

"Even for the patient with far advanced disease, the utility of mechanical support -- artificial heart pumping devices -- has become remarkable," Fonarow noted. "We can sustain patients for a time sufficiently long enough to not only allow for heart transplantation, but also to serve as definitive therapy and, even more provocatively, to support recovery of heart muscle function."

The result: over the past decade heart failure hospitalizations have actually declined, while the risk of death has plummeted 65 percent to 80 percent, Fonarow said. "What was once a dismal and depressing diagnosis, with an over 50 percent five-year mortality rate, is now a clinical scenario for which optimism and new hope emerges."

The future of heart failure treatment looks even brighter, said Yancy, given developments now under way that revolve around protein, gene and stem cell transplantation therapies designed to help patients recover more fully after a heart attack.

"It is a reality that will take some more time to be fully realized," Yancy noted. "But it is assuredly coming down the road."

That said, he admits that the status quo is not entirely rosy, given that U.S. hospitals now see roughly 500,000 new heart failure patients come through their doors each year.

The key to lowering that number: helping the public connect the dots between an unhealthy lifestyle and harm to the heart.

"For many people, heart failure is a fuzzy disease," Yancy noted. "People commonly think about their risk for a dramatic event, like a heart attack. But heart failure needs to be on everyone's consciousness because it develops quietly over time, as the heart gets weighed down by burdens such as obesity, diabetes and smoking," he explained.

"So, it's important to galvanize the public so that everyone knows that heart failure can be treated, but also prevented," Yancy said. "Because even though we can't cure it, we do know how to handle it. So, we can't approach it as if it's an inevitability. Because it's not."

More information

For more on a heart-healthy lifestyle, visit the American Heart Association.

SOURCES: Gregg C. Fonarow, M.D., professor, cardiovascular medicine and science, director, Ahmanson-UCLA Cardiomyopathy Center, and co-director, University of California, Los Angeles Preventive Cardiology Program, David Geffen School of Medicine; Clyde Yancy, M.D., past president, American Heart Association, and chief, cardiology, Northwestern Memorial Hospital, Chicago


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Despite Treatment, Employees with Depression Generate Higher Absentee Costs, According to Thomson Reuters Study
2. Women More Likely to Fail Treatment for Atrial Fibrillation
3. Social Anxiety and Panic - Alternative Treatment to Drugs and Therapy
4. Neuroimaging study may pave way for effective Alzheimers treatments
5. Nanofilm Introduces Clarity Defog It™ Anti Fog Treatment and EcoClens™ Eco-Friendly Lens Cleaner at Vision Expo East
6. Many veterans not getting enough treatment for PTSD
7. Scott & White Memorial Hospital uses device to revolutionize treatment of traumatic aortic injury
8. Allegheny General Hospital Study Demonstrates Safety and Potential Efficacy of Oral Allergy Treatment
9. Charging less for more effective treatments could reduce health care costs while improving health
10. Added Drug Aids MS Treatment
11. PTSD Treatment Still Lacking for Veterans
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Treatment Advances Improve the Odds for Heart Failure Patients 
(Date:4/28/2017)... Newark, NJ (PRWEB) , ... April 28, 2017 , ... ... Poor’s has affirmed the company’s credit rating of “A” and its outlook as “stable.” ... downgraded if capital reserves, which have fallen in recent years, dip below “capital adequacy” ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today a ... the Northeast U.S. , GlycoMark is the only clinically available blood test ... a clinically proven one- to two-week measure of hyperglycemic excursions, often related to ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... Replace tubes . These lamps offer an instant energy-saving solution for F32T8 fluorescent ... rewire fixtures or disconnect ballasts. These 50,000 hour rated lamps utilize the existing ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... that Aditya Patel M.D. has joined the revolutionary endoscopic practice under Dr. Datta. ... certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt Technique created and used ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... CITY, Calif. , April 24, 2017 ... durability, grip, protection, and comfort, announces the release of ... Powerform S8+. This most recent example of leading edge ... density grip pattern for 200% more tactile grip on ... user protection and durability. With TracTek and a suite ...
(Date:4/20/2017)... MINNEAPOLIS , April 20, 2017  Cogentix ... company focused on providing the Urology, Uro/Gyn and ... reported that Ash Keswani has joined the Company ... In this newly created position, Mr. Keswani will ... and CEO. "Our organization is delighted ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
Breaking Medicine Technology: